# PANTOPRAZOLE SODIUM DELAYED-RELEASE delayed release

NDC: 69097-531
Generic name: pantoprazole sodium granules
Labeler / Manufacturer: Cipla USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SUSPENSION
Routes: ORAL
Marketing started: 20250403

FDA application: ANDA217458

## Active ingredients

- PANTOPRAZOLE SODIUM: 40 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69097-531"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69097-531
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=195e06db-b76c-4470-b6a5-a3979c25046d